Angelika Lampert

Description of topic:
Voltage-gated sodium channels have been long a promising target for pain pharmacotherapy, particular in neuropathic pain. Dr Lampert and others have contributed to substantial increase in understanding the physiological and functional aspects of these channels, that can allow more precise targeting for pain. In addition, given the FDA approval of a novel NAV-blocking medicine for pain, an in-depth dive on the topic is more than timely.